AXSM FY 2017 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AXSMAxsome Therapeutics, Inc.

$8B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$42,557

Operating Income

-$27M

Net Income

-$29M

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$36M

Total Liabilities

$19M

Stockholders' Equity

$17M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$42,557	-$20,484	-107.8%
Operating Income	-$27M	-$28M	+1.4%
Net Income	-$29M	-$27M	-6.4%